(R)-Duloxetine Market Industry Analysis (2026-2034): Expanding...

bir ses eklendi Other

2026-05-21 10:45:29

(R)-Duloxetine Market Industry Analysis (2026-2034): Expanding Demand for Chiral APIs and Neuropathic Pain Therapies Drives Pharmaceutical Growth

Global (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period. (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...

0 Yorumlar 0 hisse senetleri 62 Views 0 önizleme